- Home
- SSB vs AXSM Comparison
SSB vs AXSM Comparison
Compare SSB & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SSB | AXSM |
|---|---|---|
| Founded | 1933 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.6B | 9.0B |
| IPO Year | 2008 | 2015 |
Fundamental Metrics
Financial Performance| Metric | SSB | AXSM |
|---|---|---|
| Price | $91.65 | $160.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 17 |
| Target Price | $118.92 | ★ $209.18 |
| AVG Volume (30 Days) | ★ 771.7K | 468.7K |
| Earning Date | 04-23-2026 | 05-18-2026 |
| Dividend Yield | ★ 2.57% | N/A |
| EPS Growth | 12.91 | ★ 38.56 |
| EPS | ★ 7.87 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.87 | $58.34 |
| Revenue Next Year | $6.37 | $54.30 |
| P/E Ratio | $11.93 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $77.74 | $86.99 |
| 52 Week High | $108.46 | $191.50 |
Technical Indicators
Market Signals| Indicator | SSB | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 29.91 | 34.37 |
| Support Level | $85.01 | $148.14 |
| Resistance Level | $100.26 | $191.13 |
| Average True Range (ATR) | 3.18 | 5.42 |
| MACD | -1.23 | -1.09 |
| Stochastic Oscillator | 6.15 | 4.78 |
Price Performance
Historical ComparisonAbout SSB SouthState Corporation
SouthState Bank Corp is a United States-based bank holding company. It provides a wide range of services and products to its customers through a wholly-owned bank subsidiary. The Bank provides retail and commercial banking services, mortgage lending services, trust and investment services, and consumer finance loans through financial centers in Alabama, Florida, Georgia, North Carolina, South Carolina, and Virginia. These services include demand, time and savings deposits, lending and credit card servicing, ATM processing, and wealth management and trust services.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.